Skip to content

All recalls FDA

FDAMedical devicesRecalled Status: Completed

Fresenius Kabi USA, LLC recalls LVP software of the Ivenix Infusion System (IIS); LVP-SW-0004

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Retroactively reported corrections from 2023: 1) A software defect may cause an incorrect (Fail-Stop) alarm when an administration set is loaded or coupled while the pump is executing the power-up sequence. May lead to delay in therapy. 2) Alert is not annunciated informing the clinician that the bolus cannot be delivered when the entered bolus dose exceeds the Care Profile Hard Rate Max limit and Rapid Bolus is selected. May lead to over infusion. Both issues were resolved in all fielded product in software version 5.8.0, which was installed in affected units May thru August 2023.
Products
  • LVP software of the Ivenix Infusion System (IIS); LVP-SW-0004
Where it was sold

US Nationwide distribution to the states of CA, CO, NJ, WI, UT.

Nationwide

Barcodes
00811505030122
Units affected
6 US
About this recall
LVP software of the Ivenix Infusion System (IIS); LVP-SW-0004